Bench to Bedside Initiative Shark Tank Pitch Day

The Sanders Tri-Institutional Therapeutics Discovery Institute and Cornell's Big Red Venture Fund present:

3rd Annual Bench to Bedside Initiative Shark Tank Pitch Day

High-profile investors will evaluate 7-minute business start-up pitches based on life science inventions from teams of scientists, physicians and young professionals from Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, and Rockefeller University.

Imran Babar, Ph.D.
Private Equity Senior Associate
OrbiMed Advisors LLC

Nicholas Bishop, Ph.D.
Biotechnology Analyst
Deerfield Management

Colleen Cuffaro, Ph.D.
Associate
Canaan Partners

Arthur Klausner, M.B.A.
Chief Executive Officer, Gem Pharmaceuticals LLC
Chief Executive Officer, Jade Pharmaceuticals Inc.

Scott Livingston 
Chairman and Chief Executive Officer
Livingston Securities LLC

Paul Maddon, M.D., Ph.D.
Vice Chairman
Progenics Pharmaceuticals Inc.

Liza Page Nelson, M.B.A.
Director
Epigenesis Pharmaceuticals LLC

Carlo Rizzuto, Ph.D.
Principal, Biotechnology Investing
Versant Ventures

Nick Veomett, Ph.D.
Associate
McKinsey & Company

Refreshments and networking to follow.

Tickets are free, but available on a first-come, first-served basis. RSVP here

Contact benchtobedsideinitiative@gmail.com for additional information
 

Thursday, November 19, 2015 at 5:30pm

Rockefeller Research Laboratories, auditorium 430 E. 67th St

Recent Activity

Event Registration Required

This event requires registration.